Literature DB >> 28078487

The role of the Nox4-derived ROS-mediated RhoA/Rho kinase pathway in rat hypertension induced by chronic intermittent hypoxia.

Wen Lu1, Jing Kang1, Ke Hu2, Si Tang1, Xiufang Zhou1, Lifang Xu1, Yuanyuan Li1, Shuhui Yu1.   

Abstract

BACKGROUND: Obstructive sleep apnea syndrome, which is a risk factor for resistant hypertension, is characterized by chronic intermittent hypoxia (CIH) and is associated with many cardiovascular diseases. CIH elicits systemic oxidative stress and sympathetic hyperactivity, which lead to hypertension. Rho kinases (ROCKs) are considered to be major effectors of the small GTPase RhoA and have been extensively studied in the cardiovascular field. Upregulation of the RhoA/ROCK signaling cascade is observed in various cardiovascular disorders, such as atherosclerosis, pulmonary hypertension, and stroke. However, the exact molecular function of RhoA/ROCK in CIH remains unclear and requires further study.
OBJECTIVE: This study aimed to investigate the role of the NADPH oxidase 4 (Nox4)-induced ROS/RhoA/ROCK pathway in CIH-induced hypertension in rats.
METHODS: Male Sprague-Dawley rats were exposed to CIH for 21 days (intermittent hypoxia of 21% O2 for 60 s and 5% O2 for 30 s, cyclically repeated for 8 h/day). We randomly assigned 56 male rats to groups of normoxia (RA) or vertically implemented CIH together with vehicle (CIH-V), GKT137831 (CIH-G), N-acetyl cysteine (NAC) (CIH-N), or Y27632 (CIH-Y). The rats in the RA group were continuously exposed to room air, whereas the rats in the other groups were exposed to CIH. Systolic blood pressure (BP) was monitored at the beginning of each week. After the experiment, renal sympathetic nerve activity (RSNA) was recorded, and serum and renal tissues were subjected to molecular biological and biochemical analyses.
RESULTS: Compared with the BP of RA rats, the BP of CIH-V rats started to increase 2 weeks after the beginning of the experiment, subsequently stabilizing at a high level at the end of the third week. CIH increased both RSNA and oxidative stress. This response was attenuated by treatment of the rats with GKT137831 or NAC. Inhibiting Nox4 activity or ROS production reduced RhoA/ROCK expression. Treatment with Y27632 reduced both BP and RSNA in rats exposed to CIH.
CONCLUSION: Hypertension can be induced by CIH in SD rats. The CIH-induced elevation of BP is at least partially mediated via the Nox4-induced ROS/RhoA/ROCK pathway.

Entities:  

Keywords:  Chronic intermittent hypoxia; Hypertension; NADPH oxidase 4; Obstructive sleep apnea; Oxidative stress; Renal sympathetic nerve activity; RhoA/ROCK pathway

Mesh:

Substances:

Year:  2017        PMID: 28078487     DOI: 10.1007/s11325-016-1449-2

Source DB:  PubMed          Journal:  Sleep Breath        ISSN: 1520-9512            Impact factor:   2.816


  67 in total

Review 1.  Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.

Authors:  Bernard Lassègue; Alejandra San Martín; Kathy K Griendling
Journal:  Circ Res       Date:  2012-05-11       Impact factor: 17.367

Review 2.  Mechanisms of sympathetic activation and blood pressure elevation by intermittent hypoxia.

Authors:  Nanduri R Prabhakar; Ganesh K Kumar
Journal:  Respir Physiol Neurobiol       Date:  2010-09-08       Impact factor: 1.931

Review 3.  RhoA/Rho-kinase and vascular diseases: what is the link?

Authors:  Kenia Pedrosa Nunes; Christine S Rigsby; R Clinton Webb
Journal:  Cell Mol Life Sci       Date:  2010-07-29       Impact factor: 9.261

4.  Endothelin receptor blockade ameliorates renal injury by inhibition of RhoA/Rho-kinase signalling in deoxycorticosterone acetate-salt hypertensive rats.

Authors:  Tsung-Ming Lee; Tun-Hui Chung; Shinn-Zong Lin; Nen-Chung Chang
Journal:  J Hypertens       Date:  2014-04       Impact factor: 4.844

5.  Contribution of RhoA/Rho-kinase/MEK1/ERK1/2/iNOS pathway to ischemia/reperfusion-induced oxidative/nitrosative stress and inflammation leading to distant and target organ injury in rats.

Authors:  A Nihal Sari; Meltem Kacan; Demet Unsal; Seyhan Sahan Firat; C Kemal Buharalioglu; Ozden Vezir; Belma Korkmaz; Tuba Cuez; Necmiye Canacankatan; Nehir Sucu; Lokman Ayaz; Lulufer Tamer Gumus; Aysegul Gorur; Bahar Tunctan
Journal:  Eur J Pharmacol       Date:  2013-12-01       Impact factor: 4.432

Review 6.  The role of obesity and obstructive sleep apnea in the pathogenesis and treatment of resistant hypertension.

Authors:  Jonathan A Marcus; Aravind Pothineni; Carolina Z Marcus; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2014-01       Impact factor: 5.369

Review 7.  NADPH oxidases: functions and pathologies in the vasculature.

Authors:  Bernard Lassègue; Kathy K Griendling
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-11-12       Impact factor: 8.311

8.  Regulation of hypoxia-inducible factor-α isoforms and redox state by carotid body neural activity in rats.

Authors:  Ying-Jie Peng; Guoxiang Yuan; Shakil Khan; Jayasri Nanduri; Vladislav V Makarenko; Vaddi Damodara Reddy; Chirag Vasavda; Ganesh K Kumar; Gregg L Semenza; Nanduri R Prabhakar
Journal:  J Physiol       Date:  2014-06-27       Impact factor: 5.182

9.  Prolonged hypoxia increases ROS signaling and RhoA activation in pulmonary artery smooth muscle and endothelial cells.

Authors:  Annie Y Chi; Gregory B Waypa; Paul T Mungai; Paul T Schumacker
Journal:  Antioxid Redox Signal       Date:  2010-03-01       Impact factor: 8.401

10.  Sestrin 2 and AMPK connect hyperglycemia to Nox4-dependent endothelial nitric oxide synthase uncoupling and matrix protein expression.

Authors:  Assaad A Eid; Doug-Yoon Lee; Linda J Roman; Khaled Khazim; Yves Gorin
Journal:  Mol Cell Biol       Date:  2013-07-01       Impact factor: 4.272

View more
  12 in total

1.  Toll-like receptor-4 deficiency alleviates chronic intermittent hypoxia-induced renal injury, inflammation, and fibrosis.

Authors:  Yan Zhang; Xiaoli Su; Fangfang Zou; Tengjuan Xu; Pinhua Pan; Chengping Hu
Journal:  Sleep Breath       Date:  2018-08-11       Impact factor: 2.816

2.  The role of NF-κB-mediated JNK pathway in cognitive impairment in a rat model of sleep apnea.

Authors:  Fan Liu; Ting-Wei Liu; Jian Kang
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

Review 3.  NADPH oxidase family proteins: signaling dynamics to disease management.

Authors:  Rizwana Begum; Shilpa Thota; Abubakar Abdulkadir; Gagandeep Kaur; Prathyusha Bagam; Sanjay Batra
Journal:  Cell Mol Immunol       Date:  2022-05-18       Impact factor: 22.096

4.  DL-Propargylglycine protects against myocardial injury induced by chronic intermittent hypoxia through inhibition of endoplasmic reticulum stress.

Authors:  Xiufang Zhou; Si Tang; Ke Hu; Zhan Zhang; Pei Liu; Yuchuan Luo; Jing Kang; Lifang Xu
Journal:  Sleep Breath       Date:  2018-05-16       Impact factor: 2.816

Review 5.  The Importance of NADPH Oxidases and Redox Signaling in Angiogenesis.

Authors:  Rodrigo Prieto-Bermejo; Angel Hernández-Hernández
Journal:  Antioxidants (Basel)       Date:  2017-05-13

6.  Establishment of a Rabbit Model of Chronic Obstructive Sleep Apnea and Application in Cardiovascular Consequences.

Authors:  Li-Fang Xu; Xiu-Fang Zhou; Ke Hu; Si Tang; Yu-Chuan Luo; Wen Lu
Journal:  Chin Med J (Engl)       Date:  2017-02-20       Impact factor: 2.628

Review 7.  RhoGTPase in Vascular Disease.

Authors:  Derek Strassheim; Evgenia Gerasimovskaya; David Irwin; Edward C Dempsey; Kurt Stenmark; Vijaya Karoor
Journal:  Cells       Date:  2019-06-06       Impact factor: 6.600

8.  Sodium Tanshinone II Sulfonate A Ameliorates Hypoxia-Induced Pulmonary Hypertension.

Authors:  Ya-Ru Bao; Jing-Wei Chen; Yan Jiang; Lin-Hui Wang; Rong Xue; Jin-Xian Qian; Guo-Xing Zhang
Journal:  Front Pharmacol       Date:  2020-05-21       Impact factor: 5.810

9.  Cardiac pathophysiology in response to environmental stress: a current review.

Authors:  Vineeta Tanwar; Aashish Katapadi; Jeremy M Adelstein; Jacob A Grimmer; Loren E Wold
Journal:  Curr Opin Physiol       Date:  2017-12-13

10.  NOX4, MDA, IMA and oxidative DNA damage: can these parameters be used to estimate the presence and severity of OSA?

Authors:  Selami Ekin; Hanifi Yildiz; Hamit Hakan Alp
Journal:  Sleep Breath       Date:  2020-05-12       Impact factor: 2.816

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.